Compare MSA & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSA | GRFS |
|---|---|---|
| Founded | 1914 | 1940 |
| Country | United States | Spain |
| Employees | 5300 | 25247 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.4B |
| IPO Year | N/A | N/A |
| Metric | MSA | GRFS |
|---|---|---|
| Price | $159.89 | $7.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $197.40 | $10.15 |
| AVG Volume (30 Days) | 299.4K | ★ 569.0K |
| Earning Date | 05-04-2026 | 07-28-2022 |
| Dividend Yield | 1.29% | ★ 1.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.78 | $4.49 |
| Revenue Next Year | $5.00 | $6.42 |
| P/E Ratio | $28.18 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $151.11 | $7.26 |
| 52 Week High | $208.92 | $11.14 |
| Indicator | MSA | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.16 | 47.21 |
| Support Level | $158.45 | $7.64 |
| Resistance Level | $165.15 | $8.24 |
| Average True Range (ATR) | 4.03 | 0.18 |
| MACD | -0.68 | -0.01 |
| Stochastic Oscillator | 22.08 | 44.02 |
MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The company's product offerings include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems, among others. The end markets for its products include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company has organized its business into four geographical operating segments that are aggregated into two reportable segments: Americas and International. The majority of its revenue is generated from the Americas segment, which is comprised of the company's operations in Northern North America and Latin America geographies.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.